Healthcare -
Biotechnology - NASDAQ - US
$ 1.235
0.406 %
$ 258 M
Market Cap
-1.74
P/E
SGMO - OPERATING INCOME
Operating Income SGMO - Sangamo Therapeutics, Inc.
-274 M
LAST VALUE
-22.25%
2 YEAR CAGR
-28.85%
5 YEAR CAGR
-26.22%
10 YEAR CAGR